BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25247756)

  • 1. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
    Omar S; Zedan A; Nugent K
    Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoplegia during cardiac surgery: current concepts and management.
    Fischer GW; Levin MA
    Semin Thorac Cardiovasc Surg; 2010; 22(2):140-4. PubMed ID: 21092891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoplegic syndrome--the role of methylene blue.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
    Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoplegia treatments: the past, the present, and the future.
    Levy B; Fritz C; Tahon E; Jacquot A; Auchet T; Kimmoun A
    Crit Care; 2018 Feb; 22(1):52. PubMed ID: 29486781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
    Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
    A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
    Lutjen DL; Arndt KL
    AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
    Busse LW; Barker N; Petersen C
    Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cardiac surgery vasoplegia trigger the postpericardiotomy syndrome?
    Edriss H; Lorenzana J; Nugent K
    Am J Med Sci; 2015 May; 349(5):463-5. PubMed ID: 25647832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
    Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.
    Kortekaas KA; Lindeman JH; Reinders ME; Palmen M; Klautz RJ; de Groot PG; Roest M
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):523-30. PubMed ID: 23736659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.